Antibody-drug conjugates (ADCs) represent a revolutionary advancement in the struggle against cancer. ADCs fuse the precision of antibodies with the lethal force of cytotoxic drugs. By transporting these potent agents directly to tumor sites, ADCs enhance treatment efficacy while reducing harm to healthy cells. This directed approach holds great pr